19-7199330-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000208.4(INSR):​c.653-14693C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.373 in 151,862 control chromosomes in the GnomAD database, including 10,823 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 10823 hom., cov: 30)

Consequence

INSR
NM_000208.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.250

Publications

5 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.438 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000208.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INSR
NM_000208.4
MANE Select
c.653-14693C>T
intron
N/ANP_000199.2P06213-1
INSR
NM_001079817.3
c.653-14693C>T
intron
N/ANP_001073285.1P06213-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INSR
ENST00000302850.10
TSL:1 MANE Select
c.653-14693C>T
intron
N/AENSP00000303830.4P06213-1
INSR
ENST00000341500.9
TSL:1
c.653-14693C>T
intron
N/AENSP00000342838.4P06213-2
INSR
ENST00000598216.1
TSL:1
n.628-14693C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.373
AC:
56560
AN:
151744
Hom.:
10813
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.265
Gnomad AMI
AF:
0.477
Gnomad AMR
AF:
0.410
Gnomad ASJ
AF:
0.426
Gnomad EAS
AF:
0.453
Gnomad SAS
AF:
0.296
Gnomad FIN
AF:
0.498
Gnomad MID
AF:
0.399
Gnomad NFE
AF:
0.406
Gnomad OTH
AF:
0.367
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.373
AC:
56573
AN:
151862
Hom.:
10823
Cov.:
30
AF XY:
0.375
AC XY:
27837
AN XY:
74186
show subpopulations
African (AFR)
AF:
0.265
AC:
10952
AN:
41394
American (AMR)
AF:
0.411
AC:
6258
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.426
AC:
1476
AN:
3468
East Asian (EAS)
AF:
0.453
AC:
2342
AN:
5172
South Asian (SAS)
AF:
0.295
AC:
1420
AN:
4820
European-Finnish (FIN)
AF:
0.498
AC:
5245
AN:
10526
Middle Eastern (MID)
AF:
0.401
AC:
118
AN:
294
European-Non Finnish (NFE)
AF:
0.406
AC:
27564
AN:
67940
Other (OTH)
AF:
0.363
AC:
764
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1789
3577
5366
7154
8943
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.390
Hom.:
32849
Bravo
AF:
0.364
Asia WGS
AF:
0.327
AC:
1136
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
14
DANN
Benign
0.89
PhyloP100
0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7254358; hg19: chr19-7199341; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.